School of Life Science, Beijing Institute of Technology (BIT), 5 South Zhongguancun Street, Haidian District, Beijing 100081, PR China.
J Ethnopharmacol. 2011 May 17;135(2):510-4. doi: 10.1016/j.jep.2011.03.063. Epub 2011 Apr 2.
Dragon's Blood from Dracaena cochinchinensis (Lour.) S.C. Chen (Yunnan, China), as a traditional Chinese medicinal herb, was shown to have certain antithrombotic effects. A new preparation process was used to extract effective components from Dragon's Blood. A 95% ethanol extract A (EA) and a precipitate B (PB) fraction were obtained and compared. Reliability of the preparation process was validated by pharmacodynamic experiments.
A rat/mouse thrombosis and blood stasis model was developed for this study, and EA and PB effects on thrombosis, platelet functions and blood coagulation activities were analyzed.
It was observed that the EA fraction had significantly better inhibitory effects than the PB fraction on thrombosis (p<0.05), platelet aggregation function (p<0.01) and anticoagulation activity (p<0.05-0.01).
The results obtained here showed that EA fraction from Dragon's Blood contained pharmacologically effective compounds with antithrombotic effects, partially improving platelet function and anticoagulation activity.
来自云南龙血树(Dracaena cochinchinensis (Lour.) S.C. Chen)的龙血竭,作为一种传统中药,已被证明具有一定的抗血栓作用。采用新的制备工艺从龙血竭中提取有效成分。获得了 95%乙醇提取物 A(EA)和沉淀物 B(PB)级分,并进行了比较。通过药效学实验验证了制备工艺的可靠性。
本研究建立了大鼠/小鼠血栓和血瘀模型,分析了 EA 和 PB 对血栓形成、血小板功能和血液凝固活性的影响。
观察到 EA 级分对血栓形成(p<0.05)、血小板聚集功能(p<0.01)和抗凝活性(p<0.05-0.01)的抑制作用明显优于 PB 级分。
这里的结果表明,龙血竭的 EA 级分含有具有抗血栓作用的药效化合物,部分改善了血小板功能和抗凝活性。